Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8391411rdf:typepubmed:Citationlld:pubmed
pubmed-article:8391411lifeskim:mentionsumls-concept:C0205466lld:lifeskim
pubmed-article:8391411lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:8391411lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:8391411lifeskim:mentionsumls-concept:C1521827lld:lifeskim
pubmed-article:8391411lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8391411lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:8391411lifeskim:mentionsumls-concept:C1522673lld:lifeskim
pubmed-article:8391411lifeskim:mentionsumls-concept:C0276498lld:lifeskim
pubmed-article:8391411pubmed:issue2lld:pubmed
pubmed-article:8391411pubmed:dateCreated1993-8-5lld:pubmed
pubmed-article:8391411pubmed:abstractTextIn purpose to protect goats against caprine arthritis encephalitis virus (CAEV), the first group of kids (I) was inoculated with purified, inactivated and adjuvant-treated virions, the second group (II) with adjuvant and the third one (III) with culture medium. 2-4 months later, the three groups were challenged with virulent CAEV by intraarticular route. On the clinical level, vaccinated and challenged kids show more early and severe arthritis than other groups. On the virological level, isolation of lentivirus from white blood cells and different organs is more important in group I than groups II and III. Therefore, vaccinations with inactivated and adjuvant-treated virions do not protect against a virulent challenge; there is an enhancement of lesions. We note that the adjuvant elicits a mild non-specific protection against virulent challenge.lld:pubmed
pubmed-article:8391411pubmed:languagefrelld:pubmed
pubmed-article:8391411pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391411pubmed:citationSubsetIMlld:pubmed
pubmed-article:8391411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391411pubmed:statusMEDLINElld:pubmed
pubmed-article:8391411pubmed:monthAprlld:pubmed
pubmed-article:8391411pubmed:issn0147-9571lld:pubmed
pubmed-article:8391411pubmed:authorpubmed-author:RussoPPlld:pubmed
pubmed-article:8391411pubmed:authorpubmed-author:VituCClld:pubmed
pubmed-article:8391411pubmed:authorpubmed-author:FontaineJ JJJlld:pubmed
pubmed-article:8391411pubmed:authorpubmed-author:VignoniMMlld:pubmed
pubmed-article:8391411pubmed:issnTypePrintlld:pubmed
pubmed-article:8391411pubmed:volume16lld:pubmed
pubmed-article:8391411pubmed:ownerNLMlld:pubmed
pubmed-article:8391411pubmed:authorsCompleteYlld:pubmed
pubmed-article:8391411pubmed:pagination131-6lld:pubmed
pubmed-article:8391411pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:meshHeadingpubmed-meshheading:8391411-...lld:pubmed
pubmed-article:8391411pubmed:year1993lld:pubmed
pubmed-article:8391411pubmed:articleTitle[Caprine arthritis-encephalitis: trial of an adjuvant vaccine preparation. I. Clinical and virological study].lld:pubmed
pubmed-article:8391411pubmed:affiliationCNEVA, Laboratoire de Pathologie des Petits Ruminants et des Abeilles, Biot, France.lld:pubmed
pubmed-article:8391411pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8391411pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8391411pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8391411pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:8391411pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8391411lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8391411lld:pubmed